$273.1m bipartisan commitment for T1D to transform access to glucose monitoring technology 

JDRF Australia has welcomed a $273.1 million bipartisan commitment for increased access to glucose monitoring technology set to change disease management options for Australians with type 1 diabetes (T1D).  

Currently, many people lose access to this technology, which is shown to improve short and long-term T1D health outcomes, when they reach 21 and subsidisation lapses, or face costs of up to $5,000 per year to self-fund continued use.  

The election commitment announced by the Coalition and swiftly matched by the federal Labor Opposition will change this, with Continuous and Flash Glucose Monitoring devices to be available under the National Diabetes Support Scheme from 1 July 2022 for a maximum of $32.50 each month for those aged 21 and older. 

People who meet the existing eligibility criteria such as under 21s, concession card holders and pregnant women will continue to receive unchanged, fully subsidised access to CGM products. 

JDRF thanks and commends both sides of politics for recognising the importance of this commitment, which will remove the inequity and unfairness many in the T1D community faced accessing technology that is regarded the standard of care.  

JDRF would also like to extend a heartfelt thank you to our community, advocates, and government leadership group whose involvement in the access for all campaign and tireless advocacy with MPs made this result possible, changing the future for the 125,000+ Australians living with T1D.  

We look forward to working with those elected to ensure this much-needed promise becomes a reality as swiftly as possible.  

As details regarding the announcement and its implementation become available, we will continue to keep the community updated.